Tezepelumab for sinusitis with nasal polyps and severe asthma
Treatments studied
Part of Immune system & allergy, Lungs & breathing clinical trials.
This trial tests a new biologic drug (tezepelumab) to see if it improves symptoms in people with both chronic sinusitis with nasal polyps and severe asthma. The goal is to reduce inflammation and help you breathe better. Participants must not have had prior sinus surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 19 years or older and able to give consent.
- You must have chronic sinusitis with nasal polyps and severe asthma.
- You cannot have had sinus surgery or nasal polyp removal before.
- You cannot be currently using oral steroids or immune-modifying drugs.
- Women who could become pregnant must use birth control and have negative pregnancy tests.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well tezepelumab, a new biologic medicine, works in real life for adults with chronic sinusitis and nasal polyps. It may help reduce symptoms like congestion and runny nose, and improve quality of life.
This study tests whether tezepelumab, a new injectable medicine, can help reduce nasal polyps and improve symptoms like nasal congestion, loss of smell, and sleep problems. You would receive the study drug while continuing your current nasal steroid spray, and your doctors would track how your symptoms change.
This study tracks how well tezepelumab works for people with chronic sinusitis and nasal polyps in real-world settings. It aims to see if this medication reduces symptoms and the need for surgery.
This trial tests a drug called tezepelumab to see if it helps control severe asthma in adults. It may be an option if your asthma is hard to manage with current treatments and you have frequent symptoms or flare-ups.
This study looks at how “biologic” medicines work in real-life care for people with severe chronic rhinosinusitis with nasal polyps (CRSwNP). It may help confirm which patients benefit and how treatment is used in everyday practice.
This study tests if tezepelumab can help reduce severe asthma attacks in children ages 5 to 11. It compares the drug to a placebo (a dummy treatment) to see if it is safe and effective.
Hear when a new Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.